MapLight Therapeutics, Inc. (MPLT) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "MPLT"
      ],
      "issuer_cik": "0001770069",
      "owner_cik": "0001789970",
      "accession_number": "0001789970-26-000016",
      "form_type": "4",
      "filing_date": "2026-09-18",
      "period_of_report": "2026-09-16",
      "issuer_name": "MapLight Therapeutics, Inc.",
      "issuer_trading_symbol": "MPLT",
      "owner_name": "Hanson Kristopher",
      "is_director": false,
      "is_officer": true,
      "is_ten_percent_owner": false,
      "is_other": false,
      "officer_title": "General Counsel",
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Voting Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": true,
      "transaction_date": "2026-09-16",
      "transaction_code": "S",
      "equity_swap_involved": false,
      "transaction_shares": 16509,
      "transaction_price_per_share": 11.67,
      "transaction_acquired_disposed": "D",
      "shares_owned_following_transaction": 137044,
      "transaction_value": 192660.03,
      "direct_or_indirect": "D",
      "footnotes": [
        {
          "id": "F1",
          "description": "This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025."
        },
        {
          "id": "F2",
          "description": "The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.38 to $12.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."
        }
      ]
    },
    {
      "tickers": [
        "MPLT"
      ],
      "issuer_cik": "0001770069",
      "owner_cik": "0001900201",
      "accession_number": "0001900201-26-000005",
      "form_type": "4",
      "filing_date": "2026-08-18",
      "period_of_report": "2026-08-14",
      "issuer_name": "MapLight Therapeutics, Inc.",
      "issuer_trading_symbol": "MLPT",
      "owner_name": "Catalyst4, Inc.",
      "is_director": false,
      "is_officer": false,
      "is_ten_percent_owner": true,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Voting Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-08-14",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 4400000,
      "transaction_price_per_share": 11.38,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 25306689,
      "transaction_value": 50072000,
      "direct_or_indirect": "I",
      "nature_of_ownership": "See footnote",
      "footnotes": [
        {
          "id": "F1",
          "description": "The shares are held of record by Catalyst4, Inc. (\"Catalyst4\"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein."
        }
      ]
    }
  ]
}

// trimmed to 2 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.